Logothetis CJ - Search Results

1

PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer.

Prensner JR, Chen W, Iyer MK, Cao Q, Ma T, Han S, Sahu A, Malik R, Wilder-Romans K, Navone N, Logothetis CJ, Araujo JC, Pisters LL, Tewari AK, Canman CE, Knudsen KE, Kitabayashi N, Rubin MA, Demichelis F, Lawrence TS, Chinnaiyan AM, Feng FY. Prensner JR, et al. Among authors: logothetis cj. Cancer Res. 2014 Mar 15;74(6):1651-60. doi: 10.1158/0008-5472.CAN-13-3159. Epub 2014 Jan 28. Cancer Res. 2014. PMID: 24473064 Free PMC article.

2

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer.

McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S, Logothetis CJ. McDonnell TJ, et al. Among authors: logothetis cj. J Urol. 1997 Feb;157(2):569-74. J Urol. 1997. PMID: 8996359

3

Structural alterations of chromosome 5 in twelve human prostate cancer cell lines.

Ozen M, Navone NM, Multani AS, Troncoso P, Logothetis CJ, Chung LW, von Eschenbach AC, Pathak S. Ozen M, et al. Among authors: logothetis cj. Cancer Genet Cytogenet. 1998 Oct 15;106(2):105-9. doi: 10.1016/s0165-4608(98)00051-x. Cancer Genet Cytogenet. 1998. PMID: 9797773

4

Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, Pathak S, von Eschenbach AC, Logothetis CJ. Navone NM, et al. Among authors: logothetis cj. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2493-500. Clin Cancer Res. 1997. PMID: 9815652

5

p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential.

Navone NM, Labate ME, Troncoso P, Pisters LL, Conti CJ, von Eschenbach AC, Logothetis CJ. Navone NM, et al. Among authors: logothetis cj. J Urol. 1999 Jan;161(1):304-8. J Urol. 1999. PMID: 10037428

6

Model systems of prostate cancer: uses and limitations.

Navone NM, Logothetis CJ, von Eschenbach AC, Troncoso P. Navone NM, et al. Among authors: logothetis cj. Cancer Metastasis Rev. 1998-1999;17(4):361-71. doi: 10.1023/a:1006165017279. Cancer Metastasis Rev. 1998. PMID: 10453280 Review.

7

Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results.

Pettaway CA, Pisters LL, Troncoso P, Slaton J, Finn L, Kamoi K, Logothetis CJ. Pettaway CA, et al. Among authors: logothetis cj. J Clin Oncol. 2000 Mar;18(5):1050-7. doi: 10.1200/JCO.2000.18.5.1050. J Clin Oncol. 2000. PMID: 10694556 Clinical Trial.

8

TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.

Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ. Navone NM, et al. Among authors: logothetis cj. Clin Cancer Res. 2000 Mar;6(3):1190-7. Clin Cancer Res. 2000. PMID: 10741751

9

Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.

Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM. Yang J, et al. Among authors: logothetis cj. Cancer Res. 2001 Jul 15;61(14):5652-9. Cancer Res. 2001. PMID: 11454720

10

Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts.

Newman RA, Yang J, Raymond M, Finlay V, Cabral F, Vourloumis D, Stephens LC, Troncoso P, Wu X, Logothetis CJ, Nicolaou KC, Navone NM. Newman RA, et al. Among authors: logothetis cj. Cancer Chemother Pharmacol. 2001 Oct;48(4):319-26. doi: 10.1007/s002800100323. Cancer Chemother Pharmacol. 2001. PMID: 11710633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

415 results

Search Page